trihexyphenidyl has been researched along with Argyria in 1 studies
Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.
Argyria: A permanent ashen-gray discoloration of the skin, conjunctiva, and internal organs resulting from long-continued use of silver salts. (Dorland, 27th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| HAYS, GB | 1 |
| LYLE, CB | 1 |
| WHEELER, CE | 1 |
1 other study available for trihexyphenidyl and Argyria
| Article | Year |
|---|---|
SLATE-GRAY COLOR IN PATIENTS RECEIVING CHLORPROMAZINE.
Topics: Argyria; Chlorpromazine; Chromatophores; Dermatitis, Phototoxic; Diagnosis, Differential; Drug Thera | 1964 |